Evommune, Inc. (EVMN)
Market Closed
17 Jul, 20:00
NYSE NYSE Primary $
12. 14
+0.43
+3.6721%
$
187.11M Market Cap
- P/E Ratio
- Div Yield
769,800 Volume
- Eps
$ 11.71
Previous Close Want to track EVMN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Evommune, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 John H. Burbank III Passport Capital LLC | 847,390 | $19.48M | $10.2M | -$9.28M | -47.63% |
 Point72 Asset Management LP Point72 Asset Management LP | 36,577 | $639,071.06 | $441,850.16 | -$197,220.9 | -30.86% |
 Joseph Castro Nuveen LLC | 12,452 | $286,271 | $151,603.1 | -$134,667.9 | -47.04% |
| RO Regan O'Neill Burkehill Global Management LP | 50,000 | $856,000 | $619,000 | -$237,000 | -27.69% |
 Li Peng China Universal Asset Management Co. Ltd. | 5,000 | $103,210 | $62,200 | -$41,010 | -39.73% |
 Kevin Roan Stempoint Capita LLP | 193,777 | $4.01M | $2.32M | -$1.69M | -42.15% |
 Jim Harding Propel Bio Management LLC | 55,664 | $1.28M | $676,874.24 | -$602,840.76 | -47.11% |
 Darin Sadow Freestone Grove Partners LP | 337,291 | $7.75M | $4.08M | -$3.67M | -47.32% |
 Mark Schafer Police & Firemen's Retirement System of New Jersey | 3,006 | $69,108 | $35,080.02 | -$34,027.98 | -49.24% |
